Corporate Social Responsibility

Political Contributions

See the full list of reports

Report on Safety, Health and Environment 2008-2009

SHE Report 09

Colleague Diversity

Patient Support

Safety and Environmental Protection in Rathdrum

At Schering-Plough, the importance of safety and environmental performance extends to the company as a whole, our people and the communities where we operate. This video tells how colleagues at our manufacturing facility in Rathdrum, Ireland make the safety of site colleagues and environmental protection a priority.



Partnership for Quality Medical Donations

PQMD logo

Schering-Plough is a proud member of PQMD.  Members - such as non-governmental organizations, pharmaceutical and medical supply manufacturers - share a common commitment to the development, dissemination and high-standard delivery of medical products to underserved people and disaster victims worldwide.



ShareGift

Gifting shares in the Merck/Schering-Plough merger exchange

Find out more



Shared Social Engagement



The Schering-Plough Approach to Corporate Social Responsibility

Schering-Plough, as a global innovation-driven pharmaceutical company, is committed to working to save lives and improve health of people around the world. 

Our mindset has transformed from being satisfied with traditional participation in corporate social responsibility projects to an innovative, science-based approach that is integrated with our daily work.  Accordingly, beginning in 2009, our program has a new name that better captures our philosophy:  Schering-Plough Shared Social Engagement.

Our Shared Social Engagement projects are focused around eight priorities, with a special emphasis on disease prevention and access to medicines in those therapeutic areas where Schering-Plough has expertise.  Highlights of Schering-Plough’s recent Shared Social Engagement initiatives include:

  • Providing more than 2,100 travel packs full of medical supplies, through Medical Assistance Programs (MAP) International to over 250 villages, in 96 developing countries, hit by natural disaster, disease, war and poverty.

  • Working with the Afya Serengeti (Health of Serengeti) project in Tanzania helping to stop, at the source, human rabies infections.

  • Providing access to pandemic influenza vaccine manufacturing technology to developing countries through a license agreement between Nobilon, Schering-Plough's human vaccine business unit, and the World Health Organization (WHO).

  • Participating in a project aimed at ending the annual deaths of about 200,000 women, mostly in the developing world, who bleed to death by postpartum hemorrhage, with initial work in the West African country, Burkina Faso.

  • Donating more than $28 million worth of products to the developing world in 2008.

  • Participating in the design and launch of the Montana Rural Health Initiative (RHI), a collaborative effort with the Montana Office of Rural Health and other key Montana stakeholders to create a dynamic network linking community-based health & wellness and prevention initiatives across the state.

  • Despite economic pressures, continuing our unique patient assistance programs which focus on low income patients without regard to assets owned.  As a result, these programs provide access to our products for many more patients -- such as the working poor and to middle class people struggling to hold onto their homes -- than would the common programs with an asset-test eligibility component.  Over $100 million in free medicines were provided to more than 70,000 patients in the U.S. through these programs in 2008.

We invite you to view our progress through this new Shared Social Engagement website.